Anaplastic large cell lymphoma (ALCL), ALK-positive, is a subtype of non-Hodgkin lymphoma characterized by the presence of anaplastic large cells and the expression of the anaplastic lymphoma kinase (ALK) protein. This aggressive malignancy primarily affects lymph nodes and can present with systemic symptoms. Accurate coding with ICD-10 Code C84.68 is essential for proper diagnosis, documentation, billing, and public health reporting, ensuring appropriate treatment and resource allocation.
ICD-10 Code C84.68 designates Anaplastic large cell lymphoma, ALK-positive, affecting multiple lymph nodes. This code is used when documenting cases of ALCL that are characterized by the presence of ALK gene rearrangements, indicating a specific biological behavior and treatment response. It is crucial for accurate clinical documentation and billing, particularly in oncology settings.
Anaplastic large cell lymphoma, ALK-positive, is a rare and aggressive form of non-Hodgkin lymphoma that typically presents in younger individuals. It is characterized by the proliferation of large, atypical lymphoid cells and is associated with specific genetic alterations. Prompt diagnosis and treatment are critical due to its aggressive nature.
ICD-10 Code C84.68 is utilized in SOAP notes to document the diagnosis of Anaplastic large cell lymphoma, ALK-positive. It plays a vital role in capturing patient symptoms, clinical assessments, and treatment plans, ensuring comprehensive documentation in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C84.68 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Anaplastic large cell lymphoma, ALK-positive. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
The management of Anaplastic large cell lymphoma, ALK-positive, often requires urgent intervention due to its aggressive nature. Treatment typically involves chemotherapy and targeted therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.68 is critical in medical billing, particularly in oncology and hospital settings, to ensure accurate claims processing.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 38221 | Bone marrow aspiration and/or biopsy. |
| 77021 | CT scan of the chest for staging. |
| 85025 | Complete blood count with differential. |
Common Questions About Using ICD-10 Code C84.68 for Anaplastic large cell lymphoma, ALK-pos, nodes mult site
What are the common symptoms of Anaplastic large cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and skin lesions.
How is Anaplastic large cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy to confirm the presence of ALK-positive anaplastic large cell lymphoma.
What treatments are available for Anaplastic large cell lymphoma?
Treatment often includes chemotherapy regimens and targeted therapies specific to ALK-positive cases. Supportive care is also essential for managing symptoms.
How does ICD-10 Code C84.68 impact billing?
ICD-10 Code C84.68 is crucial for accurate billing, ensuring that claims reflect the specific diagnosis and treatment provided, which supports reimbursement for oncology services.
Clinical Notes
SOAP notes
DAP notes
AI medical notes